secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001140361-25-019005
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences Q1 2025 revenue $6.8M up 1%; net loss narrows to $2.4M
---------------------------------------------------------------------------

- Revenue $6.8M (+1% YoY); gross margin expanded 790 bps to 53.5%.
- Net loss $2.4M (EPS -$0.58) vs $3.4M loss (-$0.96) in Q1 2024.
- Adjusted EBITDA improved to -$0.55M from -$1.3M; operating expenses fell 5% to $5.7M.
- International revenue grew 8% YoY, now 36% of total; DTC drove 32% more psoriasis patients.
- Cash at quarter-end $7.8M; operating cash flow improved to -$0.55M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/0001140361-25-019005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125019005/ef20049049_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-019005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer